Product
Placebo/ritonavir
1 clinical trial
10 indications
Indication
Post-COVID-19 SyndromeIndication
Long COVIDIndication
Long Covid-19Indication
COVID-19Indication
Post COVID-19 ConditionIndication
Post-COVID SyndromeIndication
UnspecifiedIndication
postinfectious inflammationIndication
Postinfectious DisorderClinical trial
An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering From Post-COVIDStatus: Recruiting, Estimated PCD: 2024-01-31